Testosterone and Menopause: What Women Should Know About Muscle, Weight, and Libido

Can declining testosterone cause muscle loss after 40?

Testosterone contributes to muscle physiology, but the gradual loss of muscle during midlife cannot usually be blamed on testosterone alone. Ageing, lower estrogen levels, reduced activity, inadequate protein and poor recovery are often more important contributors.

Many women first notice the change in ordinary moments.

The shopping bags feel heavier. Getting up from the floor takes more effort. Arms and legs look a little softer, even though body weight has barely changed. An exercise routine that once maintained muscle no longer seems to produce the same results.

This is not simply a cosmetic issue. From midlife onward, preserving muscle supports mobility, bone health, metabolic health, balance and the ability to remain independent later in life.

Testosterone is involved in muscle protein metabolism, but research has not established testosterone therapy as a routine treatment for age-related muscle loss in women. The international consensus statement on testosterone therapy found insufficient evidence to recommend it for increasing lean body mass, improving muscle strength or supporting general musculoskeletal health in postmenopausal women. (PubMed)

The changes women notice after 40 are more likely to reflect several overlapping processes:

• natural age-related muscle loss,
• declining estrogen,
• reduced resistance exercise,
• lower daily movement,
• insufficient protein or total energy intake,
• poor sleep and recovery,
• repeated dieting,
• chronic illness,
• and increased sedentary time.

Estrogen deserves particular attention. It affects muscle function, connective tissue, inflammation and recovery, while menopause-related changes in body composition can make muscle loss more noticeable.

This means that feeling weaker does not automatically indicate a testosterone deficiency. It is a reason to look at the larger picture.

For most women, the strongest starting point remains remarkably unglamorous: progressive strength training, adequate protein, sufficient food, restorative sleep and regular daily movement.

No hormone can permanently replace the stimulus that tells muscle, “We still need you.”

Does testosterone help women build muscle?

Testosterone can affect muscle tissue, but standard female-dose testosterone therapy has not been shown clearly enough to justify prescribing it solely for muscle building or strength.

Social media sometimes presents testosterone as a shortcut to a stronger, leaner body after menopause. The implication is that if exercise is not producing visible results, the missing ingredient must be hormonal.

That claim goes further than the evidence.

Women treated with testosterone for an appropriate medical indication should receive doses intended to keep blood levels within the normal physiological range for premenopausal women. The goal is not to create the much higher androgen exposure associated with bodybuilding or anabolic steroid use.

At these physiological doses, the most consistent benefit identified in clinical research is improvement in sexual desire and related aspects of sexual function in appropriately selected women with hypoactive sexual desire disorder. Evidence for meaningful improvements in muscle mass, strength, bone density or general physical performance remains insufficient. (PubMed)

That does not mean testosterone has no biological role in muscle. It means the clinical question is different:

Does giving testosterone to a menopausal woman reliably improve her muscle enough to outweigh the risks and justify treatment?

At present, the answer is not strong enough for testosterone to be recommended for that purpose alone.

Strength training has far better practical support. It gives the body a direct reason to retain and build muscle, while also supporting bone, glucose regulation, balance and confidence in physical movement.

The useful question is therefore not, “Which hormone will build muscle for me?”

It is, “Am I giving my muscles a regular reason—and enough resources—to stay?”

Can low testosterone cause weight gain or more belly fat?

There is no reliable evidence that low testosterone is a primary cause of menopausal weight gain, and testosterone therapy is not an established weight-loss treatment for women.

Midlife body changes are real. They are also frustratingly resistant to simple explanations.

A woman may weigh roughly the same but notice that her waist has changed. Another may gain weight despite eating no differently than before. Someone else may lose muscle while gaining fat, making her body composition change even when the scale barely moves.

Menopause can influence where body fat is stored, while ageing, sleep disruption, stress, reduced activity and declining muscle mass can all affect energy balance and metabolic health.

Testosterone is sometimes pulled into this discussion because higher androgen levels are associated with muscle development in men. But that does not mean giving testosterone to women will reverse menopausal weight gain.

Clinical guidelines do not recommend testosterone for:

• weight loss,
• reducing abdominal fat,
• improving metabolism,
• preventing age-related body changes,
• or creating a leaner physique.

Research reviewed by the international consensus panel did not establish a clinically meaningful benefit for body composition at physiological doses used in women. (PubMed)

Higher-than-physiological doses may affect muscle and fat, but they also increase the likelihood of androgenic side effects and are not considered appropriate menopause treatment.

It is also worth remembering that the relationship between androgens and metabolic health is not simply “more is better.” Some women with androgen excess, including those with conditions such as polycystic ovary syndrome, may experience insulin resistance and central fat accumulation. Hormones work within ranges and systems—not according to a universal rule that more testosterone creates a better metabolism.

For body-composition changes, a more useful approach is to examine:

• muscle-strengthening activity,
• protein and fiber intake,
• meal regularity,
• sleep quality,
• alcohol intake,
• stress load,
• medications,
• thyroid function,
• and blood sugar regulation.

Testosterone should not be treated as a weight-loss drug wearing a menopause label.

Can a blood test tell whether a woman has low testosterone?

A blood test can measure testosterone, but there is no single testosterone level that reliably diagnoses a female “testosterone deficiency syndrome” or explains symptoms such as low libido, fatigue or low mood.

This is one of the most important points in the entire discussion.

When symptoms feel hormonal, it is natural to want a number. Numbers appear objective. They promise a clear answer: low, normal or high.

Unfortunately, female testosterone testing is not that simple.

Testosterone circulates at much lower concentrations in women than in men. Some laboratory methods are less accurate at these lower levels, and results may vary between laboratories. Total testosterone, free testosterone and SHBG may all be discussed, but none can be interpreted meaningfully without clinical context.

More importantly, studies have not identified a blood level below which women reliably develop low sexual desire—or above which desire is automatically normal.

A woman can have a result toward the lower end of the laboratory range and feel entirely well. Another can have a similar result and experience distressing sexual symptoms. A third may have low desire because sex has become painful, sleep has collapsed or an antidepressant is affecting sexual response.

This is why guidelines do not recommend using a testosterone blood test to diagnose HSDD. The diagnosis is based on a careful clinical assessment, not a laboratory threshold. Testosterone testing is used primarily to establish a baseline before treatment and to help prevent excessive dosing once therapy begins. (PubMed)

A testosterone result alone also cannot diagnose the cause of fatigue, brain fog, weight gain or low mood. MedlinePlus similarly notes that testosterone testing by itself cannot diagnose a health condition; abnormal results must be interpreted alongside symptoms and other clinical information. (MedlinePlus)

So, if a commercial hormone panel labels your testosterone as “suboptimal,” that does not automatically mean you need treatment.

“Optimal” is often a marketing word rather than a recognized medical diagnosis.

Why might a clinician test testosterone before prescribing it?

Testing before treatment helps identify unusually high baseline levels and provides a reference point for monitoring. It is not used to prove that testosterone is the cause of a woman’s symptoms.

Before considering treatment, a clinician may check total testosterone and, in some cases, SHBG.

This serves several purposes.

First, an unexpectedly high testosterone level may suggest that the symptoms require a different investigation. Second, a baseline result allows the clinician to monitor whether treatment is pushing levels above the physiological range expected in women.

The purpose of treatment is not to chase a particular number or raise testosterone to the upper edge of a laboratory interval. The aim is to improve a clearly defined symptom while avoiding excessive exposure.

Monitoring matters because symptoms such as acne or increased facial hair may appear before more serious concerns become obvious. Blood levels can help show whether the dose is too high, even when a woman initially feels well.

Clinical guidance generally recommends reassessing symptoms and testosterone levels after treatment begins and periodically thereafter. Therapy should not be continued indefinitely simply because it has been prescribed once. (PubMed)

The real measure of success is not whether the laboratory number increased.

It is whether the original, distressing problem improved meaningfully without unacceptable side effects.

Who may benefit from testosterone therapy during menopause?

The best-supported candidates are postmenopausal women with persistent, distressing low sexual desire after other contributing factors have been assessed and addressed.

Testosterone therapy is not designed for every woman who feels less energetic, less interested in sex or less like herself.

A proper assessment should first explore whether low desire may be related to:

• vaginal dryness or pain,
• hot flashes and poor sleep,
• depression or anxiety,
• medication side effects,
• relationship difficulties,
• chronic stress,
• body-image concerns,
• medical illness,
• or another hormonal or metabolic condition.

This is sometimes described as a biopsychosocial assessment because sexual wellbeing is biological, psychological and social at the same time.

A clinician may ask whether the change is new or lifelong, generalized or specific to a particular situation, and whether it genuinely causes distress. They may also review medications, menopause symptoms, relationship context and physical comfort during sex.

Testosterone may be considered when low sexual desire remains persistent and troubling after modifiable contributors have been addressed. The clearest evidence applies to postmenopausal women with HSDD. The Menopause Society describes testosterone as an evidence-based therapy for HSDD in postmenopausal women, while also emphasizing that this is its sole established evidence-based indication. (The Menopause Society)

Some menopause guidance also acknowledges potential benefit for selected perimenopausal women, but the evidence base is stronger after menopause, and treatment decisions require individualized medical assessment. (The Menopause Society)

It should not be prescribed simply because:

• libido is lower than a partner’s,
• sexual frequency has changed,
• a blood result appears low,
• ageing feels frustrating,
• or an online clinic promises renewed youth and confidence.

Lower desire is not automatically a disease. Treatment is appropriate when the woman herself experiences the change as a meaningful problem.

How much improvement can testosterone realistically provide?

For appropriately selected women with HSDD, testosterone can produce a modest but meaningful improvement in sexual desire and sexual wellbeing. It is not usually a dramatic overnight transformation.

Expectation matters.

Online testimonials often describe testosterone as though someone switched the lights back on within days. Clinical research tells a quieter story.

On average, testosterone therapy may improve sexual desire, arousal, orgasmic function, pleasure and sexual responsiveness in women with HSDD. It may also reduce the distress associated with low desire. However, the average effect is moderate rather than miraculous. Reviews have found benefit, but the magnitude is generally small to moderate. (PubMed)

That can still matter.

A modest average benefit across a study population does not mean no individual woman experiences a significant improvement. It means the treatment does not work equally well for everyone and cannot guarantee a particular result.

Improvement may take several weeks to become noticeable, with the full effect taking longer. A clinician should agree in advance what improvement would count as meaningful and when treatment will be reviewed.

If there is no worthwhile benefit after an adequate monitored trial, continuing indefinitely is unlikely to make sense.

Testosterone is not expected to:

• manufacture desire in an unhappy or unsafe relationship,
• make painful sex comfortable without treating the pain,
• compensate for severe sleep deprivation,
• reverse depression,
• remove the effects of overwhelming stress,
• or restore an exact version of sexuality from twenty years earlier.

Hormones influence desire, but desire still lives inside an actual life.

What form of testosterone is generally preferred for women?

When testosterone is prescribed for menopausal HSDD, expert guidance generally favors low-dose transdermal treatment that keeps levels within the normal female physiological range.

Transdermal means the medication is absorbed through the skin, commonly as a gel or cream.

In many countries, there is no testosterone product specifically licensed for women. Clinicians may therefore prescribe a small proportion of a product manufactured for men, using careful dosing and monitoring. This is known as off-label prescribing.

Off-label does not automatically mean unsafe or experimental. It means the product has not received regulatory approval for that exact population or purpose in that country. The evidence, dose and medical supervision still matter.

The recommended female dose is much lower than the typical male dose. This is not a minor detail. Accidentally applying a male-sized amount can result in excessive testosterone exposure.

Guidelines generally advise against preparations that are difficult to dose reliably or that produce levels above the normal female range. These may include:

• testosterone pellets or implants,
• injections producing high peaks,
• high-dose products,
• and some compounded preparations with uncertain consistency.

The ISSWSH guideline recommends transdermal dosing and monitoring designed to maintain testosterone within the physiological premenopausal female range. It does not support using supraphysiological levels in an attempt to improve results. (PubMed)

The principle is simple: more is not more therapeutic.

More is simply more exposure.

Are compounded testosterone creams or pellets safer because they are “bioidentical”?

No. “Bioidentical” does not guarantee that a product is safer, more natural or more accurately dosed. Compounded hormones may have greater variability and less regulatory oversight than approved products.

The word bioidentical sounds reassuring. It suggests that the hormone fits the body perfectly and therefore carries fewer risks.

But the chemical similarity of a hormone does not tell you whether the finished product has been manufactured consistently, tested adequately or prescribed at an appropriate dose.

Compounded products may be useful in limited situations when a patient cannot use an available regulated formulation. They should not automatically be treated as the superior or more natural option.

ACOG recommends regulated menopausal hormone treatments over routinely compounded products when approved options are available. It also warns that compounded formulations may have inconsistent potency and insufficient evidence supporting marketing claims about safety or effectiveness. (ACOG)

Pellets deserve particular caution because they are inserted under the skin and cannot be easily removed once administered. They may deliver testosterone for months, and the dose cannot be quickly reduced if levels become too high or side effects develop.

A product being described as personalized does not necessarily mean its effects are easier to control.

True personalization involves selecting an appropriate treatment, using a cautious dose, monitoring symptoms and blood levels, and stopping or adjusting therapy when necessary.

Can testosterone be taken without estrogen?

Yes, testosterone can sometimes be considered whether or not a woman uses menopausal hormone therapy, but estrogen-related symptoms should still be assessed and treated appropriately.

Some women assume testosterone is simply an extra ingredient added to estrogen and progesterone. Others believe they must first take conventional menopausal hormone therapy before testosterone can be discussed.

Neither statement is universally true.

Testosterone may be considered in women who use estrogen therapy and in some who do not. The decision depends on symptoms, medical history, treatment goals and whether there are other untreated contributors to sexual difficulty.

However, low estrogen can cause vaginal dryness, tissue fragility, reduced lubrication and pain during sex. When these symptoms are present, treating them directly may be more useful than adding testosterone.

Local vaginal estrogen, vaginal moisturizers, lubricants and other treatments may improve comfort, depending on the individual situation and medical history. Menopausal hormone therapy may also help other symptoms such as hot flashes and night sweats when medically appropriate. The Menopause Society’s hormone-therapy guidance identifies estrogen-based therapy as the most effective treatment for vasomotor symptoms and the genitourinary syndrome of menopause. (PubMed)

Testosterone does not replace estrogen and should not be expected to perform estrogen’s roles throughout the body.

The question is not which hormone is “best.”

It is which problem is actually being treated.

What should you track before discussing testosterone with a clinician?

Track the symptom itself, how long it has been present, what makes it better or worse, and what else changed around the same time. This creates a more useful clinical picture than a single hormone result.

Sexual desire is difficult to remember accurately over months, especially when sleep, mood and menopause symptoms are changing at the same time.

A simple record can help you notice whether low desire occurs alongside:

• vaginal discomfort,
• cycle changes,
• night sweats,
• poor sleep,
• fatigue,
• anxiety,
• medication changes,
• stressful periods,
• alcohol use,
• relationship tension,
• or reduced physical activity.

You do not need to turn intimacy into a spreadsheet.

A brief weekly check-in is often enough:

• Did sexual thoughts or interest occur?
• Did intimacy feel appealing, neutral or unwelcome?
• Was there dryness or pain?
• Was arousal possible once intimacy began?
• Did the change bother you?
• How were sleep, stress and mood that week?
• Did any medication or hormone treatment change?

Menoup can support this kind of tracking by helping you record sexual wellbeing alongside sleep, mood, energy and other menopause symptoms. Mona AI can then help surface patterns across time—not to diagnose low testosterone, but to help you prepare more specific questions for a healthcare professional.

Sometimes the pattern points toward hormones. Sometimes it points toward pain, medication, exhaustion or stress.

Either way, clearer information leads to a better conversation.

What side effects can testosterone therapy cause in women?

At appropriately low doses, the most common side effects are acne, oilier skin and increased facial or body hair. Side effects become more likely when the dose pushes testosterone above the normal physiological range for women.

The phrase “female dose” matters.

Testosterone therapy for women is intended to restore levels to the range normally seen before menopause—not to produce the substantially higher concentrations found in men or used for bodybuilding.

When treatment is carefully prescribed and monitored, mild androgenic side effects are the ones most often reported. These can include:

• acne or oilier skin,
• increased facial or body hair,
• scalp hair thinning in women who are susceptible,
• and irritation where a gel or cream is applied.

Available clinical trials suggest that physiological transdermal doses are associated mainly with mild increases in acne and hair growth rather than severe androgenic effects. However, the evidence is limited by the relatively short duration of most studies. (PMC)

The risk changes when the dose is too high.

Excessive testosterone exposure may cause:

• noticeable facial hair growth,
• worsening acne,
• scalp hair loss,
• voice deepening,
• enlargement of the clitoris,
• menstrual or uterine bleeding,
• irritability or mood changes,
• and testosterone levels above the usual female range.

Some of these effects may not fully reverse after treatment is stopped, particularly voice deepening and clitoral enlargement. That is one reason monitoring is not optional and why treatments that deliver unpredictable or prolonged doses deserve caution.

Pellet therapy can be especially difficult to adjust because the implant remains under the skin and may continue releasing hormone for months. ACOG notes reported adverse effects from testosterone pellets including acne, increased facial hair, perceived voice changes, mood symptoms, weight gain and abnormal uterine bleeding. (ACOG)

The goal is never to keep increasing the dose until you “feel something.”

The goal is to use the lowest appropriate dose, remain within the female physiological range and stop if the risks begin to outweigh the benefit.

Can testosterone gel transfer to another person?

Yes. Testosterone gel can transfer through skin contact before it has fully dried or been washed from the application area, so careful application and handwashing are important.

A transdermal gel may look harmless once it disappears into the skin, but some medication can remain on the surface.

Depending on the product and your clinician’s instructions, sensible precautions may include:

• applying it only to the recommended area,
• washing your hands immediately afterward,
• allowing it to dry before dressing,
• covering the application site with clothing,
• avoiding direct skin contact with another person until it is safe,
• and keeping the product away from children and pets.

Repeated accidental exposure may cause androgenic effects in another person. Children are particularly vulnerable because even a small amount can be significant relative to their body size.

Do not improvise the application site or dose. A product designed for male use may come with instructions that do not reflect the much smaller amount prescribed to a woman, so the instructions from the prescribing clinician should take priority.

Does testosterone therapy increase the risk of breast cancer or heart disease?

Short-term studies using physiological doses have not identified a clear major safety signal, but the long-term effects on breast, cardiovascular and metabolic health remain uncertain.

This is where an honest answer must include the limits of what we know.

Research on testosterone therapy for women has generally followed participants for months rather than decades. Many trials also excluded women with significant cardiovascular or breast-cancer risk, which means their results cannot automatically be applied to every woman seeking treatment.

The global consensus statement concluded that short-term transdermal testosterone at physiological doses had not shown serious adverse events in the studied populations. However, safety data beyond approximately two years were insufficient, and the findings were not considered generalizable to women at high cardiometabolic risk. (PMC)

There is also no good evidence that testosterone should be used to prevent:

• cardiovascular disease,
• osteoporosis,
• dementia,
• metabolic disease,
• frailty,
• or age-related decline.

Absence of proven harm over a short study period is not the same as proof of lifelong safety.

That does not mean appropriately prescribed testosterone is inherently dangerous. It means treatment should have a clear indication, realistic goal and ongoing review rather than becoming an automatic permanent prescription.

Who should use testosterone cautiously or avoid it?

Testosterone may be unsuitable or require specialist assessment when there is pregnancy potential, androgen-sensitive disease, unexplained bleeding, significant liver disease, very high baseline testosterone or a history of hormone-sensitive cancer.

Individual risk assessment matters more than a generic checklist.

A clinician should know about your complete medical history, including:

• breast or endometrial cancer,
• unexplained vaginal bleeding,
• liver disease,
• severe acne or androgen-related hair loss,
• polycystic ovary syndrome or other androgen-excess conditions,
• cardiovascular disease or significant cardiovascular risk,
• previous blood clots,
• pregnancy or the possibility of pregnancy,
• and all prescription medicines and supplements.

Testosterone is not a contraceptive. A woman who can still become pregnant needs effective contraception because testosterone exposure during pregnancy may affect fetal development.

Women with a history of hormone-sensitive cancer should not obtain testosterone through an online clinic or beauty-focused hormone service without discussing it with the specialist responsible for their cancer care. The long-term safety evidence in these groups is limited.

Treatment should also be reconsidered when baseline testosterone is already elevated. Symptoms such as sudden facial hair growth, severe acne, scalp hair loss or voice change may point toward androgen excess rather than deficiency and require medical evaluation.

How should testosterone therapy be monitored?

Monitoring should assess both the symptom being treated and whether testosterone levels remain within the normal female physiological range. Treatment should be reviewed rather than continued automatically.

Before treatment, the clinician may assess:

• the nature and duration of low sexual desire,
• how much distress it causes,
• other menopause symptoms,
• vaginal comfort and pain,
• medications,
• mental health,
• relationship and life circumstances,
• total testosterone,
• SHBG,
• and sometimes liver function and lipid levels.

After treatment begins, testosterone levels are commonly rechecked within several weeks, with further monitoring after dose changes and periodically during continued treatment. The purpose is to prevent excessive exposure—not to adjust the dose toward a universal “optimal” target. (PubMed)

You should also monitor what is happening in real life.

Has sexual desire improved? Has the distress reduced? Is intimacy more welcome or satisfying? Have acne, facial hair, scalp hair loss or voice changes appeared?

A rising laboratory value without meaningful symptom improvement is not a successful result.

Likewise, feeling more energetic for a few days does not justify ignoring a level above the female range.

How long does testosterone take to work?

Some women notice changes in sexual desire within several weeks, while the full effect may take a few months. If there is no meaningful benefit after an adequate monitored trial, treatment should usually be stopped.

Testosterone is not an instant libido switch.

The ISSWSH guideline reports that improvement may begin after roughly four to eight weeks, with the effect developing further over subsequent months. Treatment should be evaluated against the original goal rather than vague promises of feeling “optimized.” (PubMed)

Before starting, it helps to define what improvement would actually look like.

Perhaps you want sexual thoughts to return occasionally. Perhaps you want to feel receptive to intimacy rather than indifferent. Perhaps the most important change would be less distress about the loss of desire.

A useful goal is specific enough to evaluate but flexible enough to reflect real life.

“Become the woman I was at 25” is not a fair treatment target.

“Feel some spontaneous or responsive desire again and experience less distress about intimacy” is much more useful.

What should you do if testosterone causes side effects?

Contact the prescribing clinician rather than adjusting the dose on your own. Early side effects may improve when the dose is reduced or treatment is stopped.

Do not wait for a routine appointment if you notice:

• rapid facial-hair growth,
• significant acne,
• scalp hair thinning,
• voice changes,
• clitoral enlargement,
• unexpected vaginal bleeding,
• marked irritability,
• or symptoms suggesting accidental overexposure.

The clinician may repeat blood tests, reduce the dose, change the formulation or recommend stopping treatment.

Unexpected bleeding after menopause should always be medically assessed, regardless of whether you think hormones caused it.

Voice deepening deserves particular attention because it may become permanent. The same applies to significant clitoral enlargement.

A therapy intended to improve one part of wellbeing should not be allowed to create a different problem simply because it carries the word “hormone.”

When should you talk to a doctor about low libido or possible testosterone treatment?

Speak with a qualified healthcare professional when reduced sexual desire is persistent, different from your usual pattern and personally distressing—especially when it occurs with pain, bleeding, severe fatigue, mood symptoms or other health changes.

You do not need to prove that your libido is “low enough” to deserve a conversation.

Consider making an appointment when:

• the change has lasted for several months,
• it causes distress or affects your relationship,
• sex has become painful,
• vaginal dryness or urinary symptoms are present,
• symptoms started after surgery or a medication change,
• you have persistent fatigue or low mood,
• you suspect an antidepressant or another medicine is affecting sexual function,
• or you are considering testosterone from an online or private clinic.

A helpful consultation should not begin and end with a testosterone test.

Depending on your symptoms, the clinician may explore:

• vaginal and vulval health,
• estrogen-related symptoms,
• thyroid function,
• iron deficiency,
• prolactin,
• diabetes or blood sugar problems,
• depression and anxiety,
• medication side effects,
• pelvic-floor issues,
• and relationship or life circumstances.

Low desire is a legitimate health concern. But the correct treatment depends on what is contributing to it.

Sometimes the most useful intervention is testosterone. Sometimes it is vaginal estrogen, a lubricant, pelvic-health treatment, counselling, medication adjustment, better sleep treatment or relief from pain.

Often, it is more than one thing.

What practical steps can support sexual wellbeing before or alongside treatment?

Start by addressing comfort, sleep, stress and communication rather than assuming desire must appear spontaneously. Sexual wellbeing during menopause often improves through several small changes working together.

Treat pain and dryness first

Pain is a powerful inhibitor of desire.

Regular vaginal moisturizers, suitable lubricants and medical treatments for genitourinary syndrome of menopause may improve comfort. Local vaginal estrogen is an effective treatment for many women when medically appropriate. (PubMed)

Do not repeatedly push through painful sex in the hope that desire will eventually return. The nervous system learns from experience. When intimacy repeatedly hurts, the body may begin anticipating discomfort before anything has happened.

Allow for responsive desire

Desire does not always arrive spontaneously.

Many women experience responsive desire, meaning interest develops after affection, touch or intimacy has begun—not before. This can be normal, provided the interaction is wanted and comfortable.

You do not need to feel suddenly overwhelmed by desire while unloading the dishwasher for your sexuality to be healthy.

Protect sleep where possible

A body that is repeatedly woken by night sweats, insomnia or anxiety may prioritize survival and recovery over sexual interest.

Improving sleep will not solve every libido problem, but exhaustion can make desire difficult to access.

Review medications

Antidepressants, blood-pressure medicines and several other medications may affect libido, arousal or orgasm. Never stop a prescription abruptly, but ask whether the timing, dose or choice of medicine could be reviewed.

Strengthen communication

A partner may interpret reduced desire as rejection, while you may interpret their disappointment as pressure. That cycle can make intimacy feel even less appealing.

Clear communication about comfort, pace, affection and changing needs can reduce misunderstanding. Sexual counselling or couples therapy may be useful when communication has become difficult.

Rebuild connection without a performance goal

Affection does not always need to lead to intercourse or orgasm.

Removing the assumption that every touch must progress toward sex can make physical closeness feel safer and more enjoyable.

Track patterns without judging yourself

For several weeks, note:

• desire and arousal,
• vaginal comfort,
• pain,
• sleep quality,
• stress,
• mood,
• hot flashes,
• medication changes,
• alcohol,
• and cycle patterns if you are still menstruating.

The aim is not to grade your sexuality. It is to notice context.

Menoup can help you record these changes in one place and review how sexual wellbeing relates to sleep, mood, stress and other symptoms. Mona AI can support pattern recognition over time, helping you prepare clearer observations for a medical appointment without attempting to diagnose the cause.

What should you ask before accepting a testosterone prescription?

Ask about the diagnosis, formulation, dose, monitoring plan, expected benefit and stopping rules. A responsible prescriber should be able to answer all six clearly.

Useful questions include:

1. What specific symptom are we treating?
2. Have other possible causes been assessed?
3. Is this a transdermal product, and exactly how much should I apply?
4. What blood tests are needed before and during treatment?
5. What side effects should make me contact you?
6. When will we decide whether it is working?
7. What happens if my testosterone level becomes too high?
8. Why is this formulation preferable to a pellet or compounded product?

Be cautious when a clinic:

• promises weight loss, confidence, mental clarity and muscle gain from one hormone,
• sells treatment before completing a clinical assessment,
• relies mainly on saliva testing,
• uses the term “optimal” without explaining a recognized medical target,
• recommends pellets as the default,
• encourages levels above the normal female range,
• or dismisses monitoring as unnecessary.

Personalized medicine should mean personalized care—not personalized marketing.

What are the key takeaways about testosterone and menopause?

Testosterone is a real and important female hormone, but it is not a universal explanation for every change after 40. Its strongest evidence-based use is for distressing low sexual desire in carefully assessed postmenopausal women.

• Women naturally produce testosterone, and levels generally decline gradually with age.
• Menopause-related low libido can involve testosterone, but also estrogen loss, pain, sleep, stress, medications, mood and relationship factors.
• A blood test alone cannot diagnose a female testosterone-deficiency syndrome.
• Testosterone therapy has its clearest evidence for HSDD in postmenopausal women after a biopsychosocial assessment.
• Evidence does not support testosterone as a general treatment for fatigue, brain fog, weight gain, mood, muscle loss or anti-ageing.
• Low-dose transdermal therapy is generally preferred when treatment is appropriate.
• Pellets, supraphysiological doses and inconsistent compounded products are not recommended as routine first choices.
• Acne and increased hair growth are the most common side effects; excessive dosing can cause more serious androgenic changes.
• Long-term breast and cardiovascular safety data remain limited.
• Treatment should be monitored and stopped when it does not provide a meaningful benefit.

Testosterone may be one piece of the menopause puzzle. It should never be sold as the entire picture.

Frequently Asked Questions

Is low testosterone common during menopause?

Testosterone levels generally decline gradually across adulthood, rather than falling suddenly at natural menopause. Surgical removal of both ovaries can cause a more abrupt reduction. A lower result does not automatically mean treatment is necessary. (PMC)

What are the symptoms of low testosterone in women?

There is no universally accepted symptom-based testosterone-deficiency syndrome in otherwise healthy women. Low sexual desire may be associated with androgen changes, but fatigue, low mood, brain fog and muscle loss are nonspecific and can have many other causes.

Can testosterone help with menopausal fatigue?

Current evidence does not support prescribing testosterone specifically for general fatigue. Sleep disruption, iron deficiency, thyroid problems, mood, medication and other causes should be considered first. (PMC)

Does testosterone help with weight loss?

Testosterone is not an established weight-loss treatment for menopausal women. Physiological female doses have not shown a sufficiently clear benefit for body composition to justify prescribing it for weight management.

Can testosterone improve muscle strength after menopause?

Testosterone has a biological role in muscle, but evidence does not support routine testosterone treatment solely to increase muscle mass or strength in postmenopausal women. Progressive resistance training, adequate protein and recovery remain more reliable strategies.

Can testosterone improve brain fog or mood?

Research has not established testosterone as an effective treatment for menopausal cognitive symptoms, depression or general wellbeing. These symptoms deserve assessment, but they should not automatically be attributed to low testosterone. (PMC)

Do I need a low testosterone blood result to receive treatment?

Not necessarily. Testosterone levels do not reliably diagnose HSDD. Testing is mainly used to identify unexpectedly high baseline levels and to prevent excessive dosing during treatment. (PubMed)

Can I use testosterone if I am already taking HRT?

Possibly. Testosterone may be considered in selected women whose distressing low sexual desire persists after other factors, including estrogen-related symptoms, have been addressed. The decision should be individualized.

Is testosterone for women the same as testosterone for men?

The hormone molecule may be the same, but the dose used for women is much smaller. A male-sized dose can produce excessive levels and androgenic side effects.

Is testosterone therapy licensed for women?

This varies by country. In many places, no female-specific testosterone product is licensed, so clinicians prescribe a carefully reduced dose of a male transdermal product off-label. The NHS notes that specialist prescribing may be considered for some menopausal women with low libido. (nhs.uk)

Are testosterone pellets a good option?

Most major guidelines do not recommend pellets as a routine choice because they may produce excessive levels and cannot be easily removed or adjusted after insertion. (ACOG)

How long can a woman stay on testosterone?

There is no single duration suitable for everyone. Continued treatment requires meaningful benefit, acceptable side effects and regular monitoring. Long-term safety data remain limited, so therapy should be reviewed periodically rather than renewed automatically.

Will testosterone make my voice deeper?

Voice deepening is uncommon at physiological female doses but can occur with excessive exposure. Because it may be irreversible, any noticeable voice change should be reported promptly.

Can testosterone restore the libido I had when I was younger?

It may improve desire in appropriately selected women with HSDD, but it cannot recreate a previous life stage or remove every physical, emotional and relationship influence on sexuality. The average benefit in trials is meaningful but moderate.

A natural next step

You do not need to decide whether testosterone is the answer before you understand the pattern.

Tracking libido, vaginal comfort, sleep, mood, energy, stress and medication changes over several weeks can help you see whether symptoms move together. Menoup helps keep those observations in one place, while Mona AI can highlight patterns that may be useful to discuss with a qualified healthcare professional.

The purpose is not to reduce your experience to a hormone score.

It is to help you arrive at the appointment with a clearer picture of what has changed—and what kind of support may genuinely help.

Medical Disclaimer

This article is for educational purposes only and does not provide medical advice, diagnosis or treatment. Symptoms such as low sexual desire, fatigue, mood changes, pain during sex or changes in body composition can have many causes. Testosterone should only be used following an individualized assessment by a qualified healthcare professional, with appropriate dosing and monitoring. Seek medical advice promptly for postmenopausal bleeding, sudden androgenic changes, severe mood symptoms or other persistent or concerning symptoms.